Skip to main content

Table 2 Experimental Group Design

From: Effects of ERK/p38 MAPKs signaling pathways on MTA-mediated osteo/odontogenic differentiation of stem cells from apical papilla: a vitro study

Control

0 mg/ml MTA + 10% FBS α-MEM

MTA

0.2 mg/ml MTA + 10% FBS α-MEM

MTA + SB203580

0.2 mg/ml MTA + 10% FBS α-MEM + SB203580(20 μM)

MTA + U0126

0.2 mg/ml MTA + 10% FBS α-MEM + U0126(20 μM)

  1. SB203580, inhibitor of p38; U0126, inhibitor of ERK
Back to article page

BMC Oral Health

ISSN: 1472-6831

Contact us